ATE157877T1 - Verbindung von nucleocidanaloga zur behandlung viraler infektionen - Google Patents

Verbindung von nucleocidanaloga zur behandlung viraler infektionen

Info

Publication number
ATE157877T1
ATE157877T1 AT94904110T AT94904110T ATE157877T1 AT E157877 T1 ATE157877 T1 AT E157877T1 AT 94904110 T AT94904110 T AT 94904110T AT 94904110 T AT94904110 T AT 94904110T AT E157877 T1 ATE157877 T1 AT E157877T1
Authority
AT
Austria
Prior art keywords
nucleocid
analogues
compound
treatment
viral infections
Prior art date
Application number
AT94904110T
Other languages
English (en)
Inventor
Tarek Mansour
Alan H Tse
Original Assignee
Iaf Biochem Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iaf Biochem Int filed Critical Iaf Biochem Int
Application granted granted Critical
Publication of ATE157877T1 publication Critical patent/ATE157877T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT94904110T 1992-12-24 1993-12-22 Verbindung von nucleocidanaloga zur behandlung viraler infektionen ATE157877T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929226927A GB9226927D0 (en) 1992-12-24 1992-12-24 Dideoxy nucleoside analogues

Publications (1)

Publication Number Publication Date
ATE157877T1 true ATE157877T1 (de) 1997-09-15

Family

ID=10727197

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94904110T ATE157877T1 (de) 1992-12-24 1993-12-22 Verbindung von nucleocidanaloga zur behandlung viraler infektionen

Country Status (21)

Country Link
US (1) US6156737A (de)
EP (2) EP0675724B1 (de)
JP (2) JP2818299B2 (de)
KR (1) KR100331714B1 (de)
AP (1) AP450A (de)
AT (1) ATE157877T1 (de)
AU (1) AU681370B2 (de)
CA (1) CA2143204C (de)
DE (1) DE69313872T2 (de)
DK (1) DK0675724T3 (de)
ES (1) ES2108969T3 (de)
GB (1) GB9226927D0 (de)
GR (1) GR3024699T3 (de)
HK (1) HK1002426A1 (de)
IL (1) IL108063A (de)
MY (1) MY127808A (de)
NZ (1) NZ259487A (de)
RU (1) RU2160108C2 (de)
SG (1) SG48956A1 (de)
WO (1) WO1994014456A1 (de)
ZA (1) ZA939677B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5728575A (en) * 1990-02-01 1998-03-17 Emory University Method of resolution of 1,3-oxathiolane nucleoside enantiomers
US5276151A (en) * 1990-02-01 1994-01-04 Emory University Method of synthesis of 1,3-dioxolane nucleosides
US5444063A (en) * 1990-12-05 1995-08-22 Emory University Enantiomerically pure β-D-dioxolane nucleosides with selective anti-Hepatitis B virus activity
US5817667A (en) * 1991-04-17 1998-10-06 University Of Georgia Research Foudation Compounds and methods for the treatment of cancer
TW374087B (en) * 1993-05-25 1999-11-11 Univ Yale L-2',3'-dideoxy nucleotide analogs as anti-hepatitis B(HBV) and anti-HIV agents
US5627160A (en) * 1993-05-25 1997-05-06 Yale University L-2',3'-dideoxy nucleoside analogs as anti-hepatitis B (HBV) and anti-HIV agents
WO1995007086A1 (en) 1993-09-10 1995-03-16 Emory University Nucleosides with anti-hepatitis b virus activity
US20020120130A1 (en) 1993-09-10 2002-08-29 Gilles Gosselin 2' or 3' -deoxy and 2', 3' -dideoxy-beta-L-pentofuranonucleo-side compounds, method of preparation and application in therapy, especially as anti- viral agents
US5587362A (en) * 1994-01-28 1996-12-24 Univ. Of Ga Research Foundation L-nucleosides
IL115156A (en) 1994-09-06 2000-07-16 Univ Georgia Pharmaceutical compositions for the treatment of cancer comprising 1-(2-hydroxymethyl-1,3-dioxolan-4-yl) cytosines
US6391859B1 (en) * 1995-01-27 2002-05-21 Emory University [5-Carboxamido or 5-fluoro]-[2′,3′-unsaturated or 3′-modified]-pyrimidine nucleosides
US5703058A (en) * 1995-01-27 1997-12-30 Emory University Compositions containing 5-fluoro-2',3'-didehydro-2',3'-dideoxycytidine or a mono-, di-, or triphosphate thereof and a second antiviral agent
US5808040A (en) * 1995-01-30 1998-09-15 Yale University L-nucleosides incorporated into polymeric structure for stabilization of oligonucleotides
US5869461A (en) * 1995-03-16 1999-02-09 Yale University Reducing toxicity of L-nucleosides with D-nucleosides
EP0831852B1 (de) * 1995-06-07 2006-11-29 Emory University Nucleoside mit anti-hepatitis b virus wirksamkeit
US6100301A (en) * 1996-02-28 2000-08-08 Pfizer Inc Combination therapy to treat osteoporosis-polyphosphonates and estrogen agonists
US5753789A (en) * 1996-07-26 1998-05-19 Yale University Oligonucleotides containing L-nucleosides
ZA984796B (en) * 1997-06-10 1998-12-29 Chong Kun Dang Corp Novel optically active nucleoside derivative its manufacturing method and anti-HBV composition containing the derivative thereof
US7115584B2 (en) * 1999-01-22 2006-10-03 Emory University HIV-1 mutations selected for by β-2′,3′-didehydro-2′,3′-dideoxy-5-fluorocytidine
US7635690B2 (en) 1999-01-22 2009-12-22 Emory University HIV-1 mutations selected for by β-2′,3′-didehydro-2′,3′-dideoxy-5-fluorocytidine

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
AU591125B2 (en) * 1985-05-15 1989-11-30 Wellcome Foundation Limited, The Therapeutic nucleosides
US4788181A (en) * 1986-09-29 1988-11-29 The United States Of America As Represented By The Department Of Health And Human Services 5-substituted-2',3'-dideoxycytidine compounds with anti-HTLV-III activity
EP0285884A3 (de) * 1987-03-20 1990-07-04 Bristol-Myers Squibb Company Verfahren zur Herstellung von 2',3'-Dideoxynucleoside
US5215970A (en) * 1987-04-16 1993-06-01 Medivir Ab Nucleosides and nucleotide analogues, pharmaceutical composition and processes for the preparation of the compounds
CA1327000C (en) * 1987-08-07 1994-02-15 David L.J. Tyrrell Antiviral therapy for hepatitis b
US5039667A (en) * 1987-08-07 1991-08-13 The Governors Of The University Of Alberta Antiviral therapy for hepatitis B with 2',3'-dideoxypurine nucleosides
SE8802687D0 (sv) * 1988-07-20 1988-07-20 Astra Ab Nucleoside derivatives
CA2055433A1 (en) * 1989-05-15 1990-11-16 Jay H. Hoofnagle Method of treatment of hepatitis
SE464168B (sv) * 1989-07-19 1991-03-18 Bo Fredrik Oeberg Antiviral komposition bestaaende av en 3'-fluoro-2',3'-dideoxynukleosidfoerening och en 2',3'-dideoxynukleosidfoerening (exempelvis azt)
GB9009861D0 (en) * 1990-05-02 1990-06-27 Glaxo Group Ltd Chemical compounds
US5179104A (en) * 1990-12-05 1993-01-12 University Of Georgia Research Foundation, Inc. Process for the preparation of enantiomerically pure β-D-(-)-dioxolane-nucleosides
IL100502A (en) * 1991-01-03 1995-12-08 Iaf Biochem Int PHARMACEUTICAL PREPARATIONS CONTAINING CIS-4-AMINO-1-) 2-HYDROXIMETHIL-1,3-OXETYOLEN-5-IL (-
NZ250842A (en) * 1991-02-22 1996-03-26 Univ Emory Resolution of a racemic mixture of nucleoside enantiomers such as 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane (ftc)
DE69232649T2 (de) * 1991-03-06 2002-11-28 Emory University, Atlanta Verwendung von 5-fluoro-2'-deoxy-3'-thiacytidin zur behandlung von hepatitis b
WO1992018517A1 (en) * 1991-04-17 1992-10-29 Yale University Method of treating or preventing hepatitis b virus
GB9110874D0 (en) * 1991-05-20 1991-07-10 Iaf Biochem Int Medicaments
ZA923641B (en) * 1991-05-21 1993-02-24 Iaf Biochem Int Processes for the diastereoselective synthesis of nucleosides
GB9116601D0 (en) * 1991-08-01 1991-09-18 Iaf Biochem Int 1,3-oxathiolane nucleoside analogues
TW374087B (en) * 1993-05-25 1999-11-11 Univ Yale L-2',3'-dideoxy nucleotide analogs as anti-hepatitis B(HBV) and anti-HIV agents
JPH09222548A (ja) * 1996-02-19 1997-08-26 Asahi Optical Co Ltd レンズ駆動機構

Also Published As

Publication number Publication date
HK1002426A1 (en) 1998-08-21
CA2143204C (en) 1997-06-03
SG48956A1 (en) 1998-05-18
AU5830194A (en) 1994-07-19
ZA939677B (en) 1994-08-26
AP9300603A0 (en) 1994-01-31
IL108063A0 (en) 1994-04-12
WO1994014456A1 (en) 1994-07-07
ES2108969T3 (es) 1998-01-01
RU2160108C2 (ru) 2000-12-10
GR3024699T3 (en) 1997-12-31
IL108063A (en) 1999-10-28
DE69313872T2 (de) 1998-01-08
JPH10139668A (ja) 1998-05-26
EP0675724A1 (de) 1995-10-11
GB9226927D0 (en) 1993-02-17
JP2818299B2 (ja) 1998-10-30
DK0675724T3 (da) 1998-03-09
CA2143204A1 (en) 1994-07-07
US6156737A (en) 2000-12-05
AU681370B2 (en) 1997-08-28
JPH07509730A (ja) 1995-10-26
AP450A (en) 1996-01-19
NZ259487A (en) 1997-06-24
MY127808A (en) 2006-12-29
EP0675724B1 (de) 1997-09-10
DE69313872D1 (de) 1997-10-16
KR100331714B1 (ko) 2002-11-01
EP0765665A1 (de) 1997-04-02

Similar Documents

Publication Publication Date Title
ATE157877T1 (de) Verbindung von nucleocidanaloga zur behandlung viraler infektionen
DK0821690T3 (da) Nukleotidanaloger til behandling af virusinfektioner
DE69307509D1 (de) Vorrichtung zur behandlung von herzfehlern
DE3884200D1 (de) Verfahren zur Behandlung von Mastitis und anderen Staphylokokkeninfektionen.
ATE267180T1 (de) Phosphorderivate zur behandlung von aids
DE69109401D1 (de) Wässrige Zusammensetzungen zur Behandlung von porösen Substraten.
DE69317349D1 (de) Verfahren zur Herstellung von Methylaminen
DE69420229D1 (de) Pharmazeutische Zusammensetzung zur Behandlung von AIDS
DE59308715D1 (de) Verfahren zur Herstellung von Dimethylchlorsilan
DE60006412D1 (de) Oxazinochinolone zur behandlung von viralen infektionen
DE59305389D1 (de) Verfahren zur Herstellung von alpha-Fluor -beta-dicarbonylverbindungen
DE59309150D1 (de) Verfahren zur Herstellung von E,Z-Butendial-bis-dialkylacetalen
DE59303220D1 (de) Verfahren zur Herstellung von 1-Fluorcyclopropyl-methyl-keton
DE69304687D1 (de) Verfahren zur Herstellung von Ethylbenzol
DE69314899D1 (de) Verfahren zur Herstellung von Polyaminoborazinen
DE69315297D1 (de) Verfahren zur Herstellung von Omega-Alkenylchlorsilanen
DE59309654D1 (de) Verfahren zur Herstellung von festem Natriumcyanid
DE69303057D1 (de) Verfahren zur Herstellung von 3-Cyano-6-hydroxypyridin
DE69315317D1 (de) Verfahren zur Herstellung von beta-Cyanoalkylsilanen
DE69314413D1 (de) Piperidino-3,4-dihydrocarbostyryl Verbindungen zur Behandlung von ischämischen Störungen
DE69318765D1 (de) Verfahren zur Herstellung von Hydridoorganooxysilanen
DE69309373D1 (de) Verfahren zur Herstellung von aromatischer sekundärer Amino Verbindung
DE3668116D1 (de) Zusammensetzung zur behandlung von infektionen.
DE69305279D1 (de) Verfahren zur Herstellung von Dimethyltetralin
DE59306959D1 (de) Verfahren zur Herstellung von Difluor- und Chlorfluorbenzodioxolen

Legal Events

Date Code Title Description
EEFA Change of the company name
EEFA Change of the company name
REN Ceased due to non-payment of the annual fee